Holen Sie sich die Stockscreener-App
1.15
3.36%
-0.04
Handel nachbörslich:
1.12
-0.03
-2.61%
Schlusskurs vom Vortag:
$1.19
Offen:
$1.17
24-Stunden-Volumen:
40,755
Relative Volume:
0.25
Marktkapitalisierung:
$13.31M
Einnahmen:
$996.00K
Nettoeinkommen (Verlust:
$-6.09M
KGV:
-2.1698
EPS:
-0.53
Netto-Cashflow:
$-9.76M
1W Leistung:
-12.21%
1M Leistung:
+7.25%
6M Leistung:
-19.01%
1J Leistung:
-25.76%
1-Tages-Spanne:
$1.12
$1.19
1-Wochen-Bereich:
$1.12
$1.3399
52-Wochen-Spanne:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Firmenname
Therapeuticsmd Inc
Sektor
Telefon
561-961-1900
Adresse
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Vergleichen Sie TXMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.15 | 13.77M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-08-07 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-05-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-12-02 | Eingeleitet | Guggenheim | Buy |
| 2019-10-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-04-30 | Fortgesetzt | Noble Capital Markets | Outperform |
| 2018-06-15 | Eingeleitet | JP Morgan | Overweight |
| 2017-09-08 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2017-07-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2017-05-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2016-11-22 | Fortgesetzt | Jefferies | Buy |
| 2016-11-22 | Eingeleitet | Oppenheimer | Outperform |
| 2016-11-07 | Fortgesetzt | Guggenheim | Buy |
| 2016-04-04 | Eingeleitet | Goldman | Buy |
| 2015-12-08 | Bestätigt | Jefferies | Buy |
| 2015-12-08 | Bestätigt | Stifel | Buy |
| 2015-09-21 | Bestätigt | Jefferies | Buy |
| 2015-06-09 | Eingeleitet | Guggenheim | Buy |
| 2014-07-08 | Eingeleitet | FBR Capital | Outperform |
| 2014-04-17 | Bestätigt | Noble Financial | Buy |
| 2014-01-28 | Bestätigt | Noble Financial | Buy |
Alle ansehen
Therapeuticsmd Inc Aktie (TXMD) Neueste Nachrichten
Will TherapeuticsMD Inc. stock benefit from upcoming earnings reportsEarnings Risk Summary & Detailed Earnings Play Alerts - newser.com
Can a trend reversal in TherapeuticsMD Inc. lead to recovery2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - newser.com
How TherapeuticsMD Inc. (29TA) stock correlates with oil marketsEarnings Beat & Accurate Entry and Exit Point Alerts - newser.com
Can TherapeuticsMD Inc. stock weather global recession2025 Earnings Surprises & Low Risk Entry Point Guides - newser.com
Trend analysis for TherapeuticsMD Inc. this week2025 Breakouts & Breakdowns & Daily Profit Maximizing Trade Tips - newser.com
How to build a dashboard for TherapeuticsMD Inc. stockQuarterly Performance Summary & Fast Entry and Exit Trade Plans - newser.com
Why TherapeuticsMD Inc. stock is seen as undervaluedWeekly Profit Analysis & Consistent Return Investment Signals - newser.com
How to manage a losing position in TherapeuticsMD Inc.Insider Buying & AI Based Buy/Sell Signal Reports - newser.com
Why TherapeuticsMD Inc. stock remains a top recommendation2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - newser.com
Why ETFs are accumulating TherapeuticsMD Inc. (29TA) stock2025 Technical Patterns & Precise Buy Zone Identification - newser.com
What MACD and RSI say about TherapeuticsMD Inc.July 2025 Update & Fast Gain Stock Trading Tips - newser.com
Can TherapeuticsMD Inc. stock surprise with earnings upside2025 Stock Rankings & AI Forecasted Stock Moves - newser.com
TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch
Key metrics from TherapeuticsMD Inc.’s quarterly dataPortfolio Profit Report & Precise Trade Entry Recommendations - newser.com
How to read the order book for TherapeuticsMD Inc.Weekly Trade Review & Daily Chart Pattern Signals - newser.com
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Finanzdaten der Therapeuticsmd Inc-Aktie (TXMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.35%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):